Apex 01 Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Apex 01 Study . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Apex 01 Study Today - Breaking & Trending Today

ARX517 Demonstrates Early Efficacy With Favorable Safety in Heavily Pretreated mCRPC

Published: October 26, 2023

ARX517 displayed preliminary efficacy and a strong safety profile in patients with metastatic castration-resistant prostate cancer, according to findings from the phase 1/2 APEX-01 study.

Source: onclive.com

Related Topics:

United StatesJohn ShenLos AngelesOncology Department At Jonsson Comprehensive Cancer CenterMedical Oncology DepartmentJonsson Comprehensive Cancer CenterMetastatic Castration Resistant Prostate CancerProstate CancerAntibody Drug ConjugatePsma Targeted AdcApex 01 Study Esmo Congress